Wegovy Weight Loss Pen 2.4mg is approved by the FDA for managing excess weight and helping to prevent cardiovascular complications in individuals with obesity or overweight. The medication is administered subcutaneously once a week.

Wegovy 2.4 mg Pen ingredients

Wegovy injections contain the active ingredient semaglutide, which activates GLP-1 receptors in the brain. This helps reduce appetite and slows gastric emptying, leading to prolonged satiety, reduced food intake, and subsequent weight loss.

Wegovy uses

Wegovy is FDA-approved for weight loss and long-term weight management in:

• Adults and adolescents aged 12 and older with obesity.

• Individuals who are overweight and have a weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol.

The FDA has also approved Wegovy for reducing the risk of cardiovascular complications such as heart attack or stroke in adults with cardiovascular disease and either obesity or overweight.

Wegovy is used in combination with a reduced-calorie diet and increased physical activity.

How to Use Wegovy Injections?

• Wegovy is injected once weekly, on the same day each week.

• It can be taken at any time of the day, with or without food.

• It is administered subcutaneously (under the skin).

• Injection sites include the abdomen, thigh, or upper arm.

• Rotate the injection site each time.

• Do not inject into areas of skin that are red, firm, bruised, scarred, or have stretch marks.

Wegovy Dosage

• Starting dose: 0.25 mg once weekly for the first 4 weeks.

• The doctor gradually increases the dose every 4 weeks until reaching 1.7 mg or 2.4 mg per week.

• It's essential to start with the lowest dose and increase gradually over months to minimize gastrointestinal side effects.

Wegovy Dosing Schedule (Adults)

Wegovy Pen 2.4mg side effects

Wegovy injections may cause the following side effects:

• Nausea (44%)

• Diarrhea (30%)

• Vomiting (24%)

• Constipation (24%)

• Abdominal pain (20%)

• Headache (14%)

• Fatigue (11%)

• Indigestion (9%)

• Bloating (7%)

• Belching (7%)

• Hypoglycemia in patients with type 2 diabetes (6%)

Wegovy contraindications

Wegovy injections should not be used in cases of:

• Hypersensitivity to any of its ingredients

• Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)

• Personal or family history of medullary thyroid carcinoma

• Diabetic ketoacidosis

Warnings and Precautions

Consult a doctor before using Wegovy, especially in cases of:

• Stomach or intestinal disorders

• Pancreatitis

• Kidney disease

• Planning for surgery or procedures requiring anesthesia

• Diabetic retinopathy

• Depression or other mental health disorders

Wegovy and Pregnancy

• Stop using Wegovy at least two months before conception.

• Wegovy may harm the fetus and is not recommended during pregnancy.

• Consult a doctor for safer weight loss alternatives during pregnancy.

Wegovy and Breastfeeding

• It is unknown whether Wegovy passes into breast milk.

• Consult your doctor before using Wegovy while breastfeeding.

Storage and Handling

• Store in the refrigerator at 2°C to 8°C.

• If needed, the pen can be stored at 8°C to 30°C for up to 28 days.

• Do not freeze.

• Keep in its original packaging, protected from light.

• Dispose of the pen after use.

How much weight can you lose with Wegovy injections?

It may take some time to see results from Wegovy injections, but after one year of use, an average weight loss of approximately 15% is expected.